CIK 1940272
ADAR1 Capital Management, LLC
Institutional 13F holdings & portfolio
Holdings
512
Portfolio Value
$1M+
Latest Report
Dec 31, 2025
Report Periods
1
Holdings
13F filings as of Dec 31, 2025 · Showing 1–50 of 512
| Ticker | Company | Shares | Value | Type |
|---|---|---|---|---|
| ABVX | ABIVAX SA | 1.3M | $1M+ | SH |
| ABVX | ABIVAX SA | 1.3M | $1M+ | SH |
| PTGX | PROTAGONIST THERAPEUTICS INC | 1.0M | $1M+ | SH |
| PTGX | PROTAGONIST THERAPEUTICS INC | 1.0M | $1M+ | SH |
| ROIV | ROIVANT SCIENCES LTD | 3.4M | $1M+ | SH |
| ROIV | ROIVANT SCIENCES LTD | 3.4M | $1M+ | SH |
| IMVT | IMMUNOVANT INC | 2.5M | $1M+ | SH |
| IMVT | IMMUNOVANT INC | 2.5M | $1M+ | SH |
| RNA | AVIDITY BIOSCIENCES INC | 547K | $1M+ | SH |
| RNA | AVIDITY BIOSCIENCES INC | 547K | $1M+ | SH |
| BOXX | EA SERIES TRUST | 337K | $1M+ | SH |
| BOXX | EA SERIES TRUST | 337K | $1M+ | SH |
| SPY | SPDR S&P 500 ETF TR | 55K | $1M+ | SH |
| SPY | SPDR S&P 500 ETF TR | 55K | $1M+ | SH |
| CYTK | CYTOKINETICS INC | 540K | $1M+ | SH |
| CYTK | CYTOKINETICS INC | 540K | $1M+ | SH |
| SEPN | SEPTERNA INC | 1.2M | $1M+ | SH |
| SEPN | SEPTERNA INC | 1.2M | $1M+ | SH |
| ABUS | ARBUTUS BIOPHARMA CORP | 5.4M | $1M+ | SH |
| ABUS | ARBUTUS BIOPHARMA CORP | 5.4M | $1M+ | SH |
| PCSC | PERCEPTIVE CAP SOLUTIONS COR | 2.0M | $1M+ | SH |
| ZLAB | ZAI LAB LTD | 1.2M | $1M+ | SH |
| ZLAB | ZAI LAB LTD | 1.2M | $1M+ | SH |
| TERN | TERNS PHARMACEUTICALS INC | 542K | $1M+ | SH |
| TERN | TERNS PHARMACEUTICALS INC | 542K | $1M+ | SH |
| CTMX | CYTOMX THERAPEUTICS INC | 4.2M | $1M+ | SH |
| CTMX | CYTOMX THERAPEUTICS INC | 4.2M | $1M+ | SH |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 647K | $1M+ | SH |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 647K | $1M+ | SH |
| RAPT | RAPT THERAPEUTICS INC | 510K | $1M+ | SH |
| RAPT | RAPT THERAPEUTICS INC | 510K | $1M+ | SH |
| IKT | INHIBIKASE THERAPEUTICS INC | 8.1M | $1M+ | SH |
| IKT | INHIBIKASE THERAPEUTICS INC | 8.1M | $1M+ | SH |
| BBIO | BRIDGEBIO PHARMA INC | 213K | $1M+ | SH |
| BBIO | BRIDGEBIO PHARMA INC | 213K | $1M+ | SH |
| MNPR | MONOPAR THERAPEUTICS INC | 234K | $1M+ | SH |
| MNPR | MONOPAR THERAPEUTICS INC | 234K | $1M+ | SH |
| PCVX | VAXCYTE INC | 316K | $1M+ | SH |
| PCVX | VAXCYTE INC | 316K | $1M+ | SH |
| CRNX | CRINETICS PHARMACEUTICALS IN | 309K | $1M+ | SH |
| CRNX | CRINETICS PHARMACEUTICALS IN | 309K | $1M+ | SH |
| FULC | FULCRUM THERAPEUTICS INC | 1.3M | $1M+ | SH |
| FULC | FULCRUM THERAPEUTICS INC | 1.3M | $1M+ | SH |
| PRTA | PROTHENA CORP PLC | 1.5M | $1M+ | SH |
| PRTA | PROTHENA CORP PLC | 1.5M | $1M+ | SH |
| LXEO | LEXEO THERAPEUTICS INC | 1.4M | $1M+ | SH |
| LXEO | LEXEO THERAPEUTICS INC | 1.4M | $1M+ | SH |
| TSHA | TAYSHA GENE THERAPIES INC | 2.5M | $1M+ | SH |
| TSHA | TAYSHA GENE THERAPIES INC | 2.5M | $1M+ | SH |
| CDTX | CIDARA THERAPEUTICS INC | 60K | $1M+ | SH |